Product Images Orladeyo

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Orladeyo NDC 72769-102 by Biocryst Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - orladeyo 01

Chemical Structure - orladeyo 01

Figure 1 - orladeyo 02

Figure 1 - orladeyo 02

Figure 2 - orladeyo 03

Figure 2 - orladeyo 03

PRINCIPAL DISPLAY PANEL - 150 mg Capsule Blister Card Shellpack Carton - orladeyo 04

PRINCIPAL DISPLAY PANEL - 150 mg Capsule Blister Card Shellpack Carton - orladeyo 04

PRINCIPAL DISPLAY PANEL - 110 mg Capsule Blister Card Shellpack Carton - orladeyo 05

PRINCIPAL DISPLAY PANEL - 110 mg Capsule Blister Card Shellpack Carton - orladeyo 05

This is a description of two medications named Orladeyo and Berotralstat. Orladeyo is available in capsule form and contains 10mg of the active ingredient Ertaltaapes. Berotralstat capsules contain 110mg of the active ingredient but its usage purposes are not mentioned in the text. The package includes 28 capsules with four shell packs, each containing a 7-capsule blister card. However, it is not clear what the medication is used for.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.